Skip to content

Patient zone monitoring for the early delirium risk factor detection with artificial intelligence

Patient zone monitoring for the early delirium risk factor detection with artificial intelligence - delAI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034280
Enrollment
100
Registered
2024-06-11
Start date
2024-05-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F05.9

Interventions

Group 1: Patients diagnosed with delirium according to CAM Scores during their hospital stay, which are monitored using an AI-based algorithm based on sensor data (light, noise, movement, air quality,

Sponsors

Universitätsmedizin Greifswald
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 120 Years

Inclusion criteria

Inclusion criteria: -Admission to ward C3 of the Department of Neurology -Capable of consenting independently -Presence of a consent form

Exclusion criteria

Exclusion criteria: - Isolation due to multidrug-resistant organisms - Inability of patients to read and/or speak German

Design outcomes

Primary

MeasureTime frame
Risk score for delirium during hospitalization using an AI-based algorithm based on sensordata (light, noise, movement, air quality, temperature, atmospheric pressure, humidity) in the patient environment

Secondary

MeasureTime frame
- Delirium incidence (CAM score) - Duration of delirium (days) - Delirium phenotype: hypo-/hyperactive or mixed (RASS score) - Cognitive status (MoCA) - Clinical treatment data (Demographics and social history (NINDS CDE*), Medical history (NINDS CDE*), Sensory impairment (vision aids, hearing aids), Medication history (NINDS CDE*), Substance abuse (AUDIT, NINDS CDE*), Cognitive function (Montreal Cognitive Assessment, MoCA), Surgeries, Stay in an intensive care unit, Transfusions, Complications, Number and type of accesses (e.g., cannulas, central venous catheters, arterial blood pressure measurement, nasogastric or percutaneous feeding tube, suprapubic or indwelling urinary catheter, possibly further drains), Discharge/transfer destination, Hospital stay duration) *NINDS CDE = National Institutes of Neurological Disorders and Stroke Common Data Elements(https://www.commondataelements.ninds.nih.gov/Stroke.aspx#tab=Data_Standards)

Countries

Germany

Contacts

Public ContactRobert Fleischmann

Universitätsmedizin Greifswald

delirprae@med.uni-greifswald.de03834 86-7666

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026